Global Genetic Testing Market - Industry Analysis And Market Forecast 2015-2020
|発行||Mordor Intelligence LLP||商品コード||319191|
|遺伝子検査の世界市場：産業分析、市場見通し Global Genetic Testing Market - Industry Analysis And Market Forecast 2015-2020|
|出版日: 2016年01月01日||ページ情報: 英文||
Global genetic testing market has been estimated to be valued at USD 37 billion in 2015 and is projected to reach USD 60 billion annually by 2020 with a compound annual growth rate (CAGR) of 10% during the forecast period 2015 to 2020.
Genetic testing is the analysis of chromosomes,DNA, RNA, genes or proteins to predict the risk of diseases, identify carriers of diseases and diagnose the disease or determine the likely course of a disease. Genetic testing is the most rapidly expanding segment of the worldwide molecular diagnostics market. The transformation of genetic testing from being a service-driven market to a product-driven market is expected to provide an impetus to the diagnostic companies for the expansion of their operations.
Genetic testing has become quite prevalent around the globe over the last few years with recent developments in molecular medicine and is expected to provide further impetus to this critical area. The European Commission, NIH and other organizations have recognized certain salient topics involving genetic testing that need further clarity, which include regional distribution of genetic services, suggestions for the rationalization of services, methods for improving national accreditation of genetic laboratories, long-term organization of external quality assessment, validation of next generation sequencing platforms and applications, perspectives on direct-to-consumer genetic testing.
The genetic testing market's growth is driven by increase in the genetic tests pipeline, early confirmation of genetic disorders, increasing incidence of diseases such as cancer, aging population and higher life expectancy. The technical advances, growing public awareness and demand for personalized medicine are the key factors that drive this market. The growing incidence of genetic diseases unravels new opportunities for genetic testing. However, high cost of genetic testing technologies remains as a key challenge for market growth.
The segmentation of the market for Genetic Testing is done based on Type (Carrier testing, diagnostic testing, new born screening, predictive and pre-symptomatic testing, and prenatal testing) .
Based on geographical location, the genetic testing market can be divided into North America (USA, Canada and Mexico), Europe (France, UK, Germany, Spain, Portugal, Scandinavia, Russia, and Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, New Zealand), Middle East and Africa (GCC, Egypt) and Latin America (Brazil, Colombia and Argentina).
The major players in this market are Abbott Molecular, Biocartis SA., Celera Group, Cepheid, Genentech, Inc., IntegraGen S.A, Luminex Corporation, Qiagen N.V., Roche Diagnostics Limited, Transgenomic, Inc., among others.